This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams JM, Cory S (1998) The BCL-2 protein family — arbiters of cell survival. Science 281: 1322–1326
Aguzzi A, Raeber AJ (1998) Transgenic models of neurodegeneration. Neurodegeneration: of (transgenic) mice and men. Brain Pathol 8: 695–7
Altman J (1962) Science 135: 1127
Altman J, Das GD (1965) J Comp Neurol 124: 319
Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiat Psych-Gericht Med 64: 146–148
Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippi A, Gandolfo C, Bino G et al (1986) Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of an Italian population. Neurol 36: 922–31
Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221: 1256–1264
Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH (1994) Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry 151: 1626–30
Ando Y, Suhr O, Elsalhy M (1998) Oxidative stress and amyloidosis. Histol Histopathol 13: 845–850
Anonymous (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. The Parkinson Study Group. N Engl J Med 328: 176–83
Anstead GM, Carlson KE, Katzenellenbogen JA (1997) The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62: 268–303
Archer JS (1999) NAMS/Solvay Resident Essay Award, Relationship between estrogen, serotonin, and depression. Menopause 6: 71–8
Arnold AP, Breedlove SM (1985) Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm Behav 19: 469–98
Aronica SM, Kraus WL, Katzenellenbogen BS (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91: 8517–21
Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R (1990) Women, myocardial infarction, and dementia in the very old. Behav Neural Biol 40: 1102–1106
Arouma OI, Evans PJ, Kaur H, Sutcliffe L, Halliwell B (1990) An evaluation of the antioxidant and potential pro-oxidant properties of food additives and of trolox C, vitamin E and probucol. Free Radical Res Corn 10: 143–157
Auger AP, Tetel MJ, McCarthy MM (2000) Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc Natl Acad Sci USA 97: 7551–7555
Aust SD, Morehouse LA, Thomas, CE (1985) Role of metals in oxygen radical reactions. J Free Radie Biol Med: 3–25
Avis NE, Brambilla D, McKinlay SM, Vass K (1994) A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol 4: 214–20
Baeuerle P, Baltimore D (1988) IxB: a specific inhibitor of the NF-KB transcription factor. Science 242: 540–546
Baichwal VR, Baeuerle PA (1997) Activate NF-KB or die? Curr Biol 7: R94–R96
Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans - the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25: 335–358
Baldwin AS (1996) The NF-KB and LcB proteins: New discoveries and insights. Annu Rev Immunol 14: 649–683
Baraban JM, Fiore RS, Sanghera JS, Paddon HB, Pelech SL (1993) Identification of p42 mitogenactivated protein kinase as a tyrosine kinase substrate activated by maximal electroconvulsive shock in hippocampus. J Neurochem 60: 330–6
Barber PV, Arnold AG, Evans G (1976) Recurrent hormone dependent chorea: effects of oestrogens and progestogens. Clin Endocrinol 5: 291–3
Barrett-Connor E (1997) Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95: 252–64
Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH (1999) Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 56: 1121–3
Baulieu EE (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52: 1–32
Baulieu EE, Kelly PA (1990) Hormones: From molecules to disease. Chapman and Hall, New York and London
Bayer SA (1982) Changes in the total number of dentate granule cells in juvenile and adult rats: a correlated volumetric and 3H-thymidine autoradiographic study. Exp Brain Res 46: 315–23
Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28: 325–353
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative disorders. Ann Neurol 38: 357–366
Becker JB (1990) Direct effect of 17beta-estradiol on striatum: sex differences in dopamine release. Synapse 5: 157–64
Becker JB, Beer ME (1986) The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre-and postsynaptic components. Behav Brain Res 19: 27–33
Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78: 547–581
Bedard P, Langelier P, Villeneuve A (1977) Oestrogens and extrapyramidal system. Lancet 2: 1367–8
Beg AA, Baltimore D (1996) An essential role for NF-KB in preventing TNF-K-induced cell death. Science 274: 782–784
Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB (1996) Neurobiology of corticotropin releasing factor (CRH) receptors and CRH-binding protein: implications for the treatment of CNS disorders. Mol Psych 1: 265–277
Behl C (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimers-disease. Cell Tiss Res 290: 471–480
Behl C (1999) Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 57: 301–323
Behl C, Holsboer F (1999) The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20: 441–4
Behl C (2000) Apoptosis and Alzheimer’s disease. J Neurol Transm 107: 1325–1344
Behl C, Davies J, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid 13 protein toxicity. Biochem Bioph Res Co 186: 944–950
Behl C, Davies JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid j3 protein toxicity. Cell 77: 817–827
Behl C, Moosmann B (1999) Estrogen and other antioxidants in neuroprotection: relevance to Alzheimer’s disease. In: Poli, Packer, Cadenas (eds) Free Radicals in Brain Pathophysiology. Dekker Publications New York, 22: 467–485
Behl C, Skutella T, Lezoualc’h F, Post A, Widmann M, Newton C, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51: 535–541
Behl C, Widmann M, Trapp T, Holsboer F (1995) 17–13 estradiol protects neurons from oxida-tive stress-induced cell death in vitro. Biochem Biophys Res Com 216: 17–13
Bennett MR (2000) The concept of long term potentiation of transmission at synapses. Prog Neurobiol 60: 109–37
Beral V, Bull D, Doll R, Key T, Peto R, Reeves G, Calle EE, Heath CW, Coates RJ, Liff JM, Franceschi S, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman AJ, Gallagher RP et al (1997) Breast cancer and hormone replacement therapy — collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047–1059
Bernard C (1865) Introduction a la medecine experimentale. Bailliere, Paris
Bethea CL (1993) Colocalization of progestin receptors with serotonin in raphe neurons of macaque. Neuroendocrinology 57: 1–6
Bethea CL, Gundlah C, Mirkes SJ (2000) Ovarian steroid action in the serotonin neural system of macaques. Novartis Foundation Symposium 230, 112–130.
John Wiley & Sons, Ltd Bethea CL, Mirkes SJ, Shively CA, Adams MR (2000) Steroid regulation of tryptophan hydro-xylase protein in the dorsal raphe of macaques. Biol Psych 47: 562–76
Beyer C (1999) Estrogen and the developing mammalian brain. Anat Embryol 199: 379–90
Biebl M, Cooper CM, Winkler J, Kuhn HG (2000) Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci Lett 291:17–20
Biegon A, Bercovitz H, Samuel D (1980) Serotonin receptor concentration during the estrous cycle of the rat. Brain Res 187: 221–5
Biegon A, Reches A, Snyder L, McEwen BS (1983) Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 32: 2015–21
Biesalski HK, Frank J (1995) Antioxidants in nutrition and their importance for the anti-/pro-oxidative balance in the immune system. Immun Infekt 23: 166–173
Binko J, Majewski H (1998) 17beta-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. Am J Physiol 274: H853–9
Bishop J, Simpkins JW (1994) Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5: 303–8
Bishop J, Simpkins JW (1995) Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull 36: 315–20
Blagosklonny MV (1999) A node between proliferation, apoptosis, and growth arrest. Bioessays 21: 704–9
Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM, Chase TN (1999) Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients — A crossover study. Neurology 53: 91–95
Blaustein JD, Olster DH (1989) Gonadal steroid hormone receptors and social behaviors. In: Balthazart J (ed) Advances in comparative Environmental Physiology, Vol 3. Springer, Berlin, pp 31–104
Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232: 331–56
Blum-Degen D, Haas M, Pohli S, Harth R, Romer W, Oettel M, Riederer P, Gotz ME (1998) Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death. Toxicol Appl Pharm 152: 49–55
Brace M, McCauley E (1997) Oestrogens and psychological well-being. Ann Med 29: 283–290
Braun S, Liebetrau W, Berning B, Behl C (2000) Vulnerability of clonal hippocampal cells to oxidative stress is increased by dexamethasone and associated with suppression of NF-KB. Neurosci Lett 295: 101–104
Bravo L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56: 317–333
Breckwoldt M, Karck U (2000) Tamoxifen for breast cancer prevention. Exp Clin Endocr Diab 108: 243–246
Breedlove SM (1994) Sexual differentiation of the human nervous system. Annu Rev Psychol 45: 389–418
Breitner JCS (1996) The role of antiinflammatory drugs in the prevention and treatment of Alzheimer’s disease. Annu Rev Med 47: 401–411
Brent R (1999) Functional genomics: learning to think about gene expression data. Curr Biol 9: R338–41
Brown PH, Lippman SM (2000) Chemoprevention of breast cancer. Breast Cancer Res Treat 62: 1–17
Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753–758
Buffet NC, Djakoure C, Maitre SC, Bouchard P (1998) Regulation of the human menstrual cycle. Front Neuroendocrinol 19: 151–186
Burakov D, Wong CW, Rachez C, Cheskis BJ, Freedman LP (2000) Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 275: 20928–34
Buratowski S (2000) Snapshots of RNA polymerase II transcription initiation. Curr Opin Cell Biol 12: 320–5
Burton GW, Joyce A, Ingold KU (1983) Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 221: 281–290
Butenandt A (1929) Untersuchungen über das weibliche Sexualhormon. Deut Med Wochenschr 52: 2171–2173
Cacabelos R, Alvarez A, Lombardi A, Fernandez-Novoa L, Corzo L, Perez P, Laredo M, Pichel V, Hernandez A, Varela M, Figueroa J, Prous J, Windisch M, Vigo C (2000) Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics drugs. Today 36: 415–499
Callier S, Morissette M, Grandbois M, Di Paolo T (2000) Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse 37: 245–51
Cameron HA, Woolley CS, McEwen BS, Gould E (1993) Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 56: 337–44
Campagnoli C, Biglia N, Cantamessa C, Lesca L, Sismondi P (1999) HRT and breast cancer risk: a clue for interpreting the available data. Maturitas 33: 185–190
Campard PK, Crochemore C, Rene F, Monnier D, Koch B, Loeffler JP (1997) PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol 16: 323–33
Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 4: 31–47
Canada AT, Gianella E, Nguyen TD, Mason RP (1990) The production of reactive oxygen species by dietary flavonols. Free Radical Bio Med 9: 441–449
Cannon WB (1929) Bodily changes in pain, hunger, fear and rage. Appleton, New York
Carlson LE, Sherwin BB (1998) Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 23: 583–603
Carlson LE, Sherwin BB (2000) Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause 7: 168–77
Casper RC (1998) Women’s Health: Hormones, Emotions, and Behavior. Cambridge University Press
Cassarino DS, Bennett JP (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondria) mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Rev 29: 1–25
Castner SA, Xiao L, Becker JB (1993) Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res 610: 127–34
Cattaneo E, McKay R (1990) Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347: 762–5
Caulin-Glaser T, Watson CA, Pardi R, Bender JR (1996) Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98: 36–42
Celis JE, Kruhoffer M, Gromova I, Frederiksen C, Ostergaard M, Thykjaer T, Gromov P, Yu J, Palsdottir H, Magnusson N, Omtoft TF (2000) Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett 480: 2–16
Chabbert Buffet N, Djakoure C, Maitre SC, Bouchard P (1998) Regulation of the human menstrual cycle. Front Neuroendocrin 19: 151–86
Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stem D, Winkler J, Lockhart DJ, Morris MS, Fodor SP (1996) Accessing genetic information with high-density DNA arrays. Science 274: 610–4
Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW1 (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401–6
Chiechi LM, Secreto G (2000) Factors of risk for breast cancer influencing postmenopausal long-term hormone replacement therapy. Tumori 86: 12–16
Chisolm GM, Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: An overview. Free Radie Biol Med 28: 1815–1826
Chomicka LK (1986) Effect of oestradiol on the responses of regional brain serotonin to stress in the ovariectomized rat. J Neural Transm 67: 267–73
Christ M, Meyer C, Sippel Kl, Wehling M (1995) Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochem Biophys Res Commun 213: 123–9
Christen S, Woodall AA, Shigenaga MK, Southwell-Kecly PT, Duncan MW, Ames BN (1997) y-Tocopherol traps mutagenic electrophiles such as NOx and complements z-tocopherol: Physiological implications. Proc Natl Acad Sci USA 94: 3217–3222
Chu S, Fuller PJ (1997) Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol 132: 195–9
Chu S, Mamers P, Burger HG, Fuller PJ (2000) Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab 85: 1200–5
Ciocca DR, Fanelli MA (1997) Estrogen receptors and cell proliferation in breast cancer. Trends Endocrin Met 8: 313–321
Ciocca DR, Roig LMV (1995) Estrogen receptors in human nontarget tissues - biological and clinical implications. Endocrin Rev 16: 35–62
Ciolino HP, Daschner PJ, Yeh GC (1998) Resveratrol inhibits transcription of CYP1A 1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58: 5707–5712
Clark JH, Peck EJ Jr (1979) Female sex steroids: receptors and function. Monogr Endocrinol 14: I-XII, 1–245
Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996–1002
Clemett D, Spencer CM (2000) Raloxifene - A review of its use in postmenopausal osteoporosis. Drugs 60: 379–411
Cohen RZ, Seeman MV, Gotowiec A, Kopala L (1999) Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry 156: 1059–1064
Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer I 90: 814–823
Collingwood TN, Urnov FD, Wolffe AP (1999) Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23: 255–75
Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L (1998) New goals for the U.S. Human Genome Project: 1998–2003. Science 282: 1998–2003
Cone RI, Davis GA, Goy RW (1981) Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Res Bull 7: 639–44
Cookson MR, Shaw PJ (1999) Oxidative stress and motor neurone disease. Brain Pathol 9: 165–186
Cordoba Montoya DA, Carrer HF (1997) Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. Brain Res 778: 430–8
Comer GW (1964) The early history of the oestrogenic hormones. The Sir Henry Dale Lecture for 1964
Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358–417
Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358–417
Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689–695
Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D (1996) In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 16: 2649–58
Craik FIM, Jennings JM (1992) Human memory. In: Craik FIM, Salthouse TA (eds) The handbook of Aging and Cognition Earlbaum. Hillsdale, NJ, pp 51–110
Cramer SC, Bastings EP (2000) Mapping clinically relevant plasticity after stroke. Neuropharmacol 39: 842–51
Cross AR, Jones OTG (1991) Enzymatic mechanisms of superoxide production. Biochim Biophys Acta 1057: 281–298
Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM (2000) Serine/threonine protein kinases and apoptosis. Exp Cell Res 256: 34–41
Cummings JL, Back C (1998) The cholinergic hypothesis of neuropsychiatrie symptoms in Alzheimer’s disease. Am J Geriatr Psych 6 [Suppl 1): S64–78
Curtis SH, Korach KS (2000) Steroid receptor knockout models: phenotypes and responses illustrate interactions between receptor signaling pathways in vivo. Adv Pharmacol (New York) 47: 357–80
Cynshi O, Kawabe Y, Suzuki T, Takashima Y, Kaise H, Nakamura M, Ohba Y, Kato Y, Tamura K, Hayasaka A et al (1998) Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Sci USA 95: 10123–10128
Cyr M, Calon F, Morissette M, Grandbois M, Callier S, Di Paolo T (2000) Drugs with estrogen-like potency and brain activity: Potential therapeutic application for the CNS Current Pharmaceutical Design 6: 1287–1312
Daniel JM, Fader AJ, Spencer AL, Dohanich GP (1997) Estrogen enhances performance of female rats during acquisition of a radial arm maze. Horm Behav 32: 217–25
Das NP (1971) Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem Pharmacol 20: 3435–3445
Dasilva SL, Burbach JPH (1995) The Nuclear Hormone-Receptor Family In The Brain — Classics And Orphans. Trends Neurosci 18: 542–548
De Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, van Staveren, WA, Katan MB (1998) Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr 68: 60–65
De Vries JH, Janssen K, Hollman PC, van Staveren WA, Katan MB (1997) Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett 114: 141–144
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337: 1641–1647
Deng G, Pike CJ, Cotman CW (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett 397: 50–4
Derkinderen P, Enslen H, Girault JA (1999) The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10: R24–34
Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10: 369–377
DeSombre ER, Greene GL, King WJ, Jensen EV (1984) Estrogen receptors, antibodies and hormone dependent cancer. Progr Clin Biol Res 142: 1–21
Deveraux QL, Reed JC (1999) IAP family proteins-suppressors of apoptosis. Gen Dev 13: 239–52
Dhingra K (1999) Antiestrogens — tamoxifen, SERMs and beyond. Invest New Drug 17: 285–311
Di Paolo T, Rouillard C, Bedard P (1985) 17beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol 117: 197–203
Diamond MC (1991) Hormonal effects on the development or cerebral lateralization. Psychoneuroendocrinology 16: 121–9
Dickancaite E, Nemeikaite A, Kalvelyte A, Cenas N (1998) Prooxidant character of flavonoid cytotoxicity: structure-activity relationships. Biochem Mol Biol Int 45: 923–930
Dickinson SL, Curzon G (1986) 5-Hydroxytryptamine-mediated behaviour in male and female rats. Neuropharmacology 25: 771–6
Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391–397
D’Mello SR, Galli C, Ciotti T, Calissano P (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 90: 10989–10993
Dodd RC, Du YS, Bales KR, Gao F, Paul SM (1999) Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappa B translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1–40) and lipopolysaccharides. J Neurochem 73: 1–40
Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S (1999) Mechanisms of transcriptional activation of BCL-2 gene expression by 17betaestradiol in breast cancer cells. J Biol Chem 274: 32099–107
Drake EB, Henderson VW, Stanczyk FZ, McCleary CA, Brown WS, Smith CA, Rizzo AA, Murdock GA, Buckwalter JG (2000) Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 54: 599–603
Drewes G, Lichtenberg-Kraag B, Doring F, Mandelkow EM, Biernat J, Goris J, Doree M, Mandelkow E (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11: 2131–8
Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R, Bambara RA (1998) Sequence require ments for estrogen receptor binding to estrogen response elements. J Biol Chem 273: 29321–30
Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM (1998) Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18: 1253–1258
Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999) Estradiol modulates bc1–2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 19: 1–2
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao RJ, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase akt. Science 275: 661–665
Dumont A, Hehner SP, Schmitz ML, Gustafsson JA, Liden J, Okret S, van der Saag PT, Wissink S, van der Burg B, Herrlich P, Haegeman G, De Bosscher K, Fiers W (1998) Cross-talk between steroids and NF-kappa B: what language? Trends Biochem Sci 23: 233–5
Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidem Biomar 8: 843–854
Ebadi M, Srinivasan SK, Baxi MD (1996) Oxidative stress and antioxidant therapy in Parkin-son’s disease. Progress in Neurobiology 48: 1–19
Eikelenboom P, Rozemuller AJM, Hoozemans JJM, Veerhuis R, van Gool WA (2000) Neuroinflammation and Alzheimer disease: Clinical and therapeutic implications. Alz Dis Ass Dis 14 [Suppl 1]: S54—S61
El Kossi MMH, Zakhary MM (2000) Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31: 1889–1892
Ellis RJ, Hartl FU (1999) Principles of protein folding in the cellular environment. Curr Opin Struc Biol 9: 102–10
Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA (1997) Human estrogen receptor-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82: 4258–65
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Albom AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4: 1313–7
Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Bio Med 11: 81–128
Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Henne-kens CH, Taylor JO (1989) Prevalence of Alzheimer’s disease in a community population of older persons. J Am Med Ass 262: 2551–2556
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889–95
Fahn S (1999) Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Arch Neurol 56: 529–535
Farr SA, Banks WA, Morley JE (2000) Estradiol potentiates acetylcholine and glutamate-mediated post-trial memory processing in the hippocampus. Brain Res 864: 263–9
Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM (1997) Comparative study of radical scavenger and antioxidant properties of phenolic compounds from vitis vinifera cell cultures using in vitro tests. Life Sci 61: 2103–2110
Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type. Psychoneuroendocrinology 11: 337–45
Finch CE, Cohen DM (1997) Aging metabolism, and Alzheimer disease — review and hypotheses. Exp Neurol 143: 82–102
Fink BE, Mortensen DS, Stauffer SR, Aron ZD, Katzenellenbogen JA (1999) Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chem Biol 6: 205–19
Fink G, Sumner BE, Rosie R, Grace O, Quinn JP (1996) Estrogen control of central neurotrans-mission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16: 325–44
Finkbeiner S (2000) Calcium regulation of the brain-derived neurotrophic factor gene. Cell Mol Life Sci 57: 394–401
Finkbeiner S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25: 11–14
Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC (1993) Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 153: 73–9
Fiorelli G, Gori F, Frediani U, Franceschelli F, Tanini A, Tosti-Guerra C, Benvenuti S, Gennari L, Becherini L, Brandi ML Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells. J Steroid Biochem & Mol Biol 59: 233–40 (1996)
Flood JF, Morley JE, Roberts E (1992) Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89: 1567–71
Floor E (2000) Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson’s disease. Cell Mol Biol 46: 709–720
Flynn BL, Ranno AE (1999) Pharmacologic management of Alzheimer disease part II: Anti-oxidants, antihypertensives, and ergoloid derivatives. Ann Pharmacotherapy 33: 188–197
Foley P, Riederer P (2000) Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease. J Neurol 247 [Suppl 2]: I182–94
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN (1995) The protein kinase encoded by the akt proto-oncogene is a target of the pdgfactivated phosphatidylinositol 3-kinase. Cell 81: 727–736
Frankfurt M, Gould E, Woolley CS, McEwen BS (1990) Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: a Golgi study in the adult rat. Neuroendocrinology 51: 530–5
Freedman LP (1999) Strategies for transcriptional activation by steroid/nuclear receptors. J Cell Biochem [Suppl 32–33]: 32–33
Friedhoff P, von Bergen M, Mandelkow EM, Mandelkow E (2000) Structure of tau protein and assembly into paired helical filaments. Biochim Biophys Acta — Molecular Basis of Disease 1502: 122–132
Friedman WJ, Greene LA (1999) Neurotrophin signaling via Trks and p75. Exp Cell Res 253: 131–42
Frohlich J, Ogawa S, Morgan M, Burton L, Pfaff D (1999) Hormones, genes and the structure of sexual arousal. Behav Brain Res 105: 5–27
Frye CA, Duncan JE (1994) Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats. Brain Res 643: 194–203
Fuhrmann U, Parczyk K, Klotzbucher M, Klocker H, Cato AC (1998) Recent developments in molecular action of antihormones. J Mol Med 76: 512–24
Gage FH (1994) Neuronal stem cells: their characterization and utilization. Neurobiol Aging 15 [Suppl 2]: S191
Gage FH (1998) Cell therapy. Nature 392 [6679 Suppl S]: 18–24
Gage FH (2000) Mammalian neural stem cells. Science 287: 1433–1438
Galea LA, Kavaliers M, Ossenkopp KP (1996) Sexually dimorphic spatial learning in meadow voles Microtus pennsylvanicus and deer mice Peromyscus maniculatus. J Exp Biol 199 (Pt 1): 195–200
Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523–7
Gandy S (1999) Neurohormonal signaling pathways and the regulation of Alzheimer betaamyloid precursor metabolism. Trends Endocrin Met 10: 273–279
Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA (1998) Estradiol upregulates BCL-2 expression in adult brain neurons. Neuroreport 9: 593–7
Garcia-Segura LM, Naftolin F, Hutchison JB, Azcoitia I, Chowen JA (1999) Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol 40: 574–84
Gamier M, lorenzo D, Albertini A, Maggi A (1997) Identification of estrogen-responsive genes in neruoblastoma SK-ER3 cells. J Neurosci 17: 4591–4599
Gate L, Paul J, Ba GN, Tew KD, Tapiero H (1999) Oxidative stress induced in pathologies: the role of antioxidants. Biomed Pharmacother 53: 169–180
Gee KW, Bolger MB, Brinton RE, Coirini H, McEwen BS (1988) Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246: 803–12
Genazzani AR, Gastaldi M, Bidzinska B, Mercuri N, Genazzani AD, Nappi RE, Segre A, Petraglia F (1992) The brain as a target organ of gonadal steroids. Psychoneuroendocrinology 17: 385–90
Ghosh A, Greenberg ME (1995) Calcium signaling in neurons - molecular mechanisms and cellular consequences. Science 268: 239–247
Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions. Science 290: 985–989
Gibbs RB (2000) Oestrogen and the cholinergie hypothesis: implications for oestrogen replacement therapy in postmenopausal women, Novartis Foundation Symposium 230: 94–107, John Wiley & Sons, Ltd.
Gibbs RB, Aggarwal P (1998) Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer’s disease-related cognitive decline. Horm Behav 34: 98–111
Giguere V (1999) Orphan nuclear receptors: From gene to function. Endocr Rev 20: 689–725
Giguere V, Tremblay A, Tremblay GB (1998) Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids 63: 335–9
Giguere V, Yang N, Segui P, Evans RM (1988) Identification of a new class of steroid hormone receptors. Nature 331: 91–4
Gilligan DM, Quyyumi AA, Cannon RO 3rd (1994) Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545–51
Gillum LA, Mamidipudi SK, Johnston SC (2000) Ischemic stroke risk with oral contraceptives - A meta-analysis. Jama 284: 72–78
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Com 120: 885–890
Goodenough S, Engert S, Behl C (2000) Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogenactivated protein kinase pathway. Neurosci Lett 296: 49–52
Goodman RH, Smolik S (2000) CBP/p300 in cell growth, transformation, and development. Gen Dev 14: 1553–1577
Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippo-campal neurons. J Neurochem 66: 1836–44
Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ (1999a) Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2: 260–5
Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E (1997) Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17: 2492–8
Gould E, Reeves AJ, Fallah M, Tanapat P, Gross CG, Fuchs E (1999b) Hippocampal neurogenesis in adult Old World primates. Proc Natl Acad Sci USA 96: 5263–7
Gould E, Tanapat P, McEwen BS, Flugge G, Fuchs E (1998) Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 95: 3168–71
Gouras GK, Xu HX, Gross RS, Greenfield JP, Hai B, Wang R, Greengard P (2000) Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid peptides. Proc Natl Acad Sci USA 97: 1202–1205
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–37
Grandbois M, Morissette M, Cahier S, Di Paolo T (2000) Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. Neuroreport 11: 343–6
Grazzini E, Guillon G, Mouillac B, Zingg HH (1998) Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392: 509–12
Green PS, Bishop J, Simpkins JW (1997) 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17: 511–5
Green PS, Gordon K, Simpkins JW (1997) Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem 63: 229–235
Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Intern J Develop Neurosci 18: 347–358
Green S, Chambon P (1988) Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4: 309–14
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Human oestro-gen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134–9
Greene GL, Closs LE, Fleming H, DeSombre ER, Jensen EV (1977) Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. Proc Natl Acad Sci USA 74: 3681–5
Greene GL, Sobel NB, King WJ, Jensen EV (1984) Immunochemical studies of estrogen receptors. J Steroid Biochem 20: 51–6
Gridley KE, Green PS, Simpkins JW (1997) Low concentrations of estradiol reduce beta-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778:25–35
Gridley KE, Green PS, Simpkins JW (1998) A novel, synergistic interaction between 17betaestradiol and glutathione in the protection of neurons against beta-amyloid 25–35-induced toxicity in vitro. Mol Pharmacol 54: 25–35
Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate though blockade of NF-KB activation. Science 274: 1383–1385
Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769–75
Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Henne-kens CH (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453–61
Groner B, Hynes NE, Rahmsdorf U, Ponta H (1983) Transcription initiation of transfected mouse mammary tumor virus LTR DNA is regulated byglucocorticoid hormones. Nucl Acids Res 11: 4713–25
Gu G, Rojo AA, Zee MC, Yu J, Simerly RB (1996) Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J Neurosci 16: 3035–44
Gu Q, Moss RL (1996) 17beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J Neurosci 16: 3620–9
Gudino-Cabrera G, Nieto-Sampedro M (1999) Estrogen receptor immunoreactivity in Schwann-like brain macroglia. J Neurobiol 40: 458–70
Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229–234
Gur RC, Gur RE, Obrist WD, Hungerbuhler JP, Younkin D, Rosen AD, Skolnick BE Reivich M (1982) Sex and handedness differences in cerebral blood flow during rest and cognitive activity. Science 217: 659–61
Gur RC, Mozley LH, Mozley PD, Resnick SM, Karp JS, Alavi A, Arnold SE, Gur RE (1995) Sex differences in regional cerebral glucose metabolism during a resting state. Science 267: 528–31
Gustafsson JA (1999) Estrogen receptor beta-a new dimension in estrogen mechanism of action. J Endocrinol 163: 379–83
Gustafsson JA (2000) An update on estrogen receptors. Semin Perinatol 24: 66–9 Haass C (1997) Presenilins: genes for life and death. Neuron 18: 66–9
Haass C, Mandelkow E (1999) Proteolysis by presenilins and the renaissance of tau. Trends Cell Biol 9: 241–4
Haass C, Selkoe DJ (1993) Cellular processing of ß-amyloid precursor protein and the genesis of amylod I3-peptide. Cell 75: 1039–1042
Hacia JG, Brody LC, Chee MS, Fodor SP, Collins FS (1996) Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet 14: 441–7
Hackman BW, Galbraith D (1976) Replacement therapy and piperazine oestrone sulphate (’Harmogen’) and its effect on memory. Curr Med Res Opin 4: 303–6
Hafner H, Anderheiden W (1997) Epidemiology of schizophrenia. Can J Psychiatry 42: 139–151
Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–41
Haleem DJ, Kennett GA, Curzon G (1990) Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT. J Neural Transm — Gen 79: 93–101
Hall ED, Pazara KE, Linseman KL (1991) Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11: 292–8
Halliday G, Robinson SR, Shepherd C, Kril J (2000) Alzheimer’s disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27: 1–8
Halliday GM, Shepherd CE, McCann H, Reid WGJ, Grayson DA, Broe GA, Kril JJ (2000) Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Arch Neurol 7: 831–836
Halliwell B (2000) The antioxidant paradox. Lancet 355: 1179–1180
Hammerschmidt DE, Knabe AC, Silberstein PT, Lamche HR, Coppo PA (1988) Inhibition of granulocyte function by steroids is not limited to corticoids. Studies with sex steroids. Inflammation 12: 277–84
Hammond CB (1996) Menopause and hormone replacement therapy: an overview. Obstet Gynecol 87 [2 Suppl]: 2S–15S
Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (—)A9-tetrahydrocanna-binol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268–8273
Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/killing. J Immunol Methods 119: 203–210
Hanson MG Jr, Shen S, Wiemelt AP, McMorris FA, Barres BA (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18: 7361–71
Hanstein B, Liu H, Yancisin MC, Brown M (1999) Functional analysis of a novel estrogen receptor-beta isoform. Mol Endocrinol 13: 129–37
Hardy J (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci 20: 154–159
Harlan RE (1988) Regulation of neuropeptide gene expression by steroid hormones. Mol Neurobiol 2: 183–200
Harman D (1998) Aging: phenomena and theories. Ann NY Acad Sci 854: 1–7
Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK (2000) The role of CBP in estrogen receptor cross-talk with nuclear factor-kappa B in HepG2 cells. Endocrinology 141: 3403–3411
Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM (1995) Direct evidence of oxida-tive injury produced by the Alzheimer’s ß-amyloid peptide (1–40) in cultured hippocampal neurons. Exp Neurol 131: 1–40
Hassan A, Markus HS (2000) Genetics and ischaemic stroke. Brain 123: 1784–1812
Heck S, Lezoualc’h F, Engert S, Behl C (1999) Insulin-like growth factor-l-mediated neuropro-tection against oxidative stress is associated with activation of nuclear factor kappa B. J Biol Chem 274: 9828–9835
Hippeli S, Elstner EF (1997) OH-radical-type reactive oxygen species: a short review on the mechanisms of OH-radical-and peroxynitrite toxicity. Zeitschrift für Naturforschung. Section C. Journal of Biosciences 52: 555–563
Heller W (1993) Gender differences in depression: perspectives from neuropsychology. J Affect Disorders 29: 129–43
Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR (2000) Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54: 295–301
Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG (1994) Estrogen replacement therapy in older women. Arch Neurol 51: 896–900
Herbison AE (1998) Multimodal influence of estrogen upon Gonadotropin-releasing hormone neurons. Endocr Rev 19: 302–330
Heritage AS, Stumpf WE, Sar M, Grant LD (1980) Brainstem catecholamine neurons are target sites for sex steroid hormones. Science 207: 1377–9
Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T (1984) Alzheimer’s disease: a study of epidemiological aspects. Ann Neurol 15: 335–41
Holliday R (1998) Causes of aging. Ann NY Acad Sci 854: 61–71
Hollman PC, van Trijp JM, Mengelers MJ, de Vries JH, Katan MB (1997) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 114: 139–140
Holsboer F, Barden N (1996) Antidepressants and hypothalamic pituitary adrenocortical regulation. Endocr Rev 17: 187–205
Honjo H, Ogino Y, Naitoh K, Urabe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T et al (1989) In vivo effects by estrone sulfate on the central nervous systemsenile dementia (Alzheimer’s type). J Steroid Biochem 34: 521–5
Horvath TL, Garciasegura LM, Naftolin F (1997) Control of gonadotropin feedback — the possible role of estrogen-induced hypothalamic synaptic plasticity. Gynecol Endocrinol 11: 139–143
Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L (1996) Nuclear receptor coactivators and corepressors. Mol Endocrinol 10: 1167–77
Hosli E, Hosli L (1999) Cellular localization of estrogen receptors on neurones in various regions of cultured rat CNS: coexistence with cholinergic and galanin receptors. Int J Dev Neurosci 17: 317–30
Howell A, Osborne CK, Morris C, Wakeling AE (2000) ICI 182,780 (Faslodex): development of a novel, “pure” antiestrogen. Cancer 89: 817–25
Hoyer S (1995) Age-related changes in cerebral oxidative metabolism — implications for drug therapy. Drug Aging 6: 210–218
Hsu SY, Hsueh AJ (2000) Discovering new hormones, receptors, and signaling mediators in the genomic era. Mol Endocrinol 14: 594–604
Hunt K, Vessey M, McPherson K (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97: 1080–6
Hum PD, Macrae IM (2000) Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20: 631–652
Hutchison JB (1993) Aromatase: neuromodulator in the control of behavior. J Steroid Biochem Mol Biol 44: 509–20
Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O’Donnell TF Jr, Korach KS, Mendelsohn ME (1997) Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3: 545–8
Ignarro LJ (1999) Nitric oxide: a unique endogenous signaling molecule in vascular biology. Bioscience Rep 19: 51–71
Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96: 4686–91
Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT (1997) A-beta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein v717f (pdapp) transgenic mouse. J Neurosci 17: 7053–7059
Isaev NK, Stelmashook EV, Halle A, Harms C, Lautenschlager M, Weih M, Dirnagl U, Victorov IV, Zorov DB (2000) Inhibition of Na(+), K(+)-ATPase activity in cultured rat cerebellar granule cells prevents the onset of apoptosis induced by low potassium. Neurosci Lett 283: 41–4
Isgor C, Sengelaub DR (1998) Prenatal gonadal steroids affect adult spatial behavior, CAI and CA3 pyramidal cell morphology in rats. Horm Behav 34: 183–98
Jaiswal RK, Weissinger E, Kolch W, Landreth GE (1996) Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90. J Biol Chem 271: 23626–9
James VHT, Serio M, Giusti G (1976) The Endocrine Function of the Human Ovary. Proc Serono Symposia, Volume 7. Academic Press, London, New York, San Francisco
Jefferson WN, Newbold RR (2000) Potential endocrine-modulating effects of various phyto-estrogens in the diet. Nutrition 16: 658–62
Jellinger KA (1999) The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson’s disease. Drug Aging 14: 115–40
Jensen EV, DeSombre ER (1973) Estrogen-receptor interaction. Science 182: 126–34
Jensen EV, Jacobson HI (1962) Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 18: 387–414
Ji L, Mochon E, Arcinas M, Boxer LM (1996) CREB proteins function as positive regulators of the translocated bel-2 allele in t(14–18) lymphomas. J Biol Chem 271: 14–18
Joel PB, Traish AM, Lannigan DA (1998) Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273: 13317–23
Joels M (1997) Steroid hormones and excitability in the mammalian brain. Front Neuroendocrin 18: 2–48
Jolly-Tornetta C, Wolf BA (2000) Regulation of amyloid precursor protein (APP) secretion by protein kinase C alpha in human ntera 2 neurons (NT2N). Biochemistry 39: 7428–7435
Jordan VC (1999) Targeted antiestrogens to prevent breast cancer. Trends Endocrin Met 10: 312–317
Jung-Testas I, Baulieu EE (1998) Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J Steroid Biochem Molec Biol 65: 243–51
Kaipia A, Hsueh AJW (1997) Regulation of ovarian follicle atresia. Annu Rev Physiol 59: 349–363
Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 94: 2642–7
Kaltschmidt C, Kaltschmidt B, Baeuerle PA (1993) Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev 43: 135–47
Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA (1994) Constitutive NF-kappa B activity in neurons. Mol Cell Biol 14: 3981–92
Kampen DL, Sherwin BB (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83: 979–83
Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253: 210–229
Karas RH, Patterson BL, Mendelsohn ME (1994) Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89: 1943–50
Karin M (1999) How NF-kappa B is activated: the role of the I kappa B kinase (IKK) complex. Oncogene 18: 6867–6874
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491–4
Kato S, Masuhiro Y, Watanabe M, Kobayashi Y, Takeyama K, Endoh H, Yanagisawa J (2000) Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways. Gen Cells 5: 593–601
Katzenellenbogen JA, Katzenellenbogen BS (1996) Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. Chem Biol 3: 529–36
Kavaliers M, Ossenkopp KP, Prato FS, Innes DG, Galea LA, Kinsella DM, Perrot-Sinal TS (1996) Spatial learning in deer mice: sex differences and the effects of endogenous opioids and 60 Hz magnetic fields. J Comp Physiol A Neural Behav Physiol 179: 715–24
Kawakami M, Yoshioka E, Konda N, Arita J, Visessuvan S (1978) Data on the sites of stimulatory feedback action of gonadal steroids indispensable for luteinizing hormone release in the rat. Endocrinol 102: 791–8
Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 48: 1517–21
Kelley ST, Thackray VG (1999) Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms. J Mol Evol 49: 609–14
Kew JN, Smith DW, Sofroniew MV (1996) Nerve growth factor withdrawal induces the apoptotic death of developing septal cholinergic neurons in vitro: protection by cyclic AMP analogue and high potassium. Neuroscience 70: 329–39
Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GL, Schnaper HW (1996) Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94: 1402–7
Kimura D (1992) Sex differences in the brain. Sci Am 267: 118–25
King WJ, Greene GL (1984) Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307: 745–7
Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36(5): 550–4
Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB (1996) Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology 21: 575–92
Klein-Hitpass L, Ryff el GU, Heitlinger E, Cato AC (1988) A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucl Acids Res 16: 647–63
Klein-Hitpass L, Schwerk C, Kahmann S, Vassen L (1998) Targets of activated steroid hormone receptors: basal transcription factors and receptor interacting proteins. J Mol Med 76: 490–6
Kliewer SA, Lehmann JM, Willson TM (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science 284: 757–60
Klinge CM (2000) Estrogen receptor interaction with co-activators and co-repressors. Steroids 65:227–51
Knazek RA, Lippmann ME, Chopra HC (1977) Formation of solid human mammary carcinoma in vitro. J Natl Cancer Inst 58: 419–22
Knierim JJ (2000) LTP takes route in the hippocampus. Neuron 25: 504–6
Kompoliti K (1999) Estrogen and movement disorders. Clin Neuropharmacol 22: 318–26
Konnecke R, Hafner H, Maurer K, Loffler W, an der Heiden W (2000) Main risk factors for schizophrenia: increased familial loading and pre-and peri-natal complications antagonize the protective effect of oestrogen in women. Schizophr Res 44: 81–93
Korach KS (1994) Insights from the study of animals lacking functional estrogen receptor. Science 266: 1524–7
Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP (1996) Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51: 159–88
Kow LM, Mobbs CV, Pfaff DW (1994) Roles of second-messenger systems and neuronal activity in the regulation of lordosis by neurotransmitters, neuropeptides, and estrogen: a review. Neurosci Biobehav R 18: 251–68
Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies 0 (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95: 15677–82
Kudo T, Imaizumi K, Tanimukai H, Katayama T, Sato N, Nakamura Y, Tanaka T, Kashiwagi Y, Jinno Y, Tohyama M, Takeda M (2000) Are cerebrovascular factors involved in Alzheimer’s disease? Neurobiol Aging 21: 215–224
Kueng W, Wirz-Justice A, Menzi R, Chappuis-Arndt E (1976) Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocrinology 21: 289–96
Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16: 2027–33
Kuiper GG, Brinkmann AO (1994) Steroid hormone receptor phosphorylation: is there a physiological role? Mol Cell Endocrinol 100: 103–7
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925–30
Kuiper GG, Shughrue PJ, Merchenthaler I, Gustafsson JA (1998) The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrin 19: 253–86
Kuiper GG, van den Bemd GJ, van Leeuwen JP (1999) Estrogen receptor and the SERM concept. J Endocrinol Invest 22: 594–603
Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11: 424–31
Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB (1995) Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lip 30: 141–6
Lacroix AZ, Burke W (1997) Breast cancer and hormone replacement therapy. Lancet 350: 1042–1043
Lafferty FW, Fiske ME (1994) Postmenopausal estrogen replacement: a long-term cohort study. Am J Med 97: 66–77
Lambert JJ, Belelli D, Hill-Yenning C, Peters JA (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16: 295–303
Landfield PW, Eldridge JC (1994) The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium. Annals NY Acad Sci 746: 308–26
Landfield PW (1988) Hippocampal neurobiological mechanisms of age-related memory dysfunction. Neurobiol Aging 9: 571–9
Langub MC Jr, Watson RE Jr (1992) Estrogen receptor-immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence: electron microscopy. Endocrinology 130: 364–72
Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW (1997) Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273: L119–26
Le Mellay V, Grosse B, Lieberherr M (1997) Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem 272: 11902–7
Lee CK, Weindruch R, Prolla TA (2000) Gene-expression profile of the ageing brain in mice. Nat Genet 25: 294–7
Lee MM, Lin SS (2000) Dietary fat and breast cancer. Annu Rev Nutr 20: 221–248
Lee TH (2000) By the way, doctor… I’m 68, and I’ve been taking Viagra for about a year now. The drug is working for me, but I’m always a little scared that I am going to give myself a heart attack. Should I be? Harvard Health Letter 25: 8
Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, van der Burg B (1999) Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48: 55–66
Lemmen JG, Broekhof JLM, Kuiper GGJM, Gustafsson JA, van der Saag PT, van der Burg B (1999) Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mech Develop 81: 163–167
Leo C, Chen JD (2000) The SRC family of nuclear receptor coactivators. Gene 245: 1–11
Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH (1998) Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson’s disease. Hum Genet 103: 424–427
Levenson AS, Jordan VC (1998) The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor. Cancer Res 58: 1872–1875
Levin ER (2000) Nuclear receptor versus plasma membrane oestrogen receptor. Novartis Foundation Symposium 230, 41–50
Lewin B (1974) Interaction of regulator proteins with recognition sequences of DNA. Cell 2: 1–7
Lewin B (2000) Genes VII. Oxford University Press, Cell Press, Cambridge
Lezoualc’h F, Behl C (1998) Transcription factor NF-KB: friend or foe of neurons? Mol Psychiatry 3: 15–2
Lezoualc’h F, Engert S, Berning B, Behl C (2000) Corticotropin-releasing hormone-mediated neuroprotection is associated with an increased release of non-amyloidogenic amyloid protein precursor and with the suppression of NF-x13. Mol Endocrinol 14: 147–159
Lezoualc’h F, Sparapani M, Behl C (1998) N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-KB. J Pin Res 24: 168–178
Lezoualc’h F, Rupprecht R, Holsboer F, Behl C (1996) Bc1–2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol. Brain Res 738: 1–2
Li HY, Bian JS, Kwan YW, Wong TM (2000) Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: Involvement of a cyclic AMP-dependent pathway. J Pharmacol Exp Ther 293: 592-598
Li HY, Bian JS, Kwan YW, Wong TM (2000) Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: Involvement of a cyclic AMP-dependent pathway. J Pharmacol Exp Ther 293: 592–598
Li NX, Karin M (1999) Is NF-kappa B the sensor of oxidative stress? FASEB J 13: 1137–1143
Li X, Schwartz PE, Rissman EF (1997) Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology 66: 63–7
Liaw JJ, He JR, Hartman RD, Barraclough CA (1992) Changes in tyrosine hydroxylase mRNA levels in medullary Al and A2 neurons and locus coeruleus following castration and estrogen replacement in rats. Brain Res Mol Brain Res 13: 231–8
Lien EJ, Ren S, Bui HH, Wang R (1999) Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radical Bio Med 26: 285–294
Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME (1998) Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 83: 224–9
Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, Shah N, Shen N, Yang R, Fodor SP (1995) Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19: 442–7
Lipton SA (1997) Janus faces of NF-xB: neurodestruction versus neuroprotection. Nature Med 3: 20–22
Liu GT, Zhang TM, Wang BE, Wang YW (1992) Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 43: 147–152
Liu ZG, Hsu HL, Goeddel DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-K13 activation prevents cell death. Cell 87: 565–576
Longcope C (1986) Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 15: 213–28
Longcope C, Franz C, Morello C, Baker R, Johnston CC Jr (1986) Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 8: 189–96
Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by beta-amyloidin cultured central nervous system neurons. Proc Natl Acad Sci USA 90: 7951–5
Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM (1994) Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89: 1501–10
Love RR (1995) Tamoxifen Chemoprevention — Public health goals, toxicities for all and benefits to a few. Ann Oncol 6: 127–128
Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852–6
Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL (1991) Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 115: 860–4
Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ (1994) Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch Intern Med 154 (22): 2585–8
Love S (1999) Oxidative stress in brain ischemia. Brain Pathol 9: 119–131
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O X1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90: 11162–6
Lucassen PJ, Chung WC, Kamphorst W, Swaab DF (1997) DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 56: 887–900
Lucking CB, Abbas N, Durr A, Bonifati V, Bonnet AM, Debroucker T, Demichele G, Wood NW, Agid Y, Brice A (1998) Homozygous deletions in parkin gene in european and north african families with autosomal recessive juvenile parkinsonism. Lancet 352: 1355–1356
Luine VN, Khylchevskaya RI, McEwen BS (1975) Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 86: 293–306
Luine VN, Richards ST, Wu VY, Beck KD (1998) Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Horm Behav 34: 149–62
Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ (1999) Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10: 117–39
Luskin MB, Zigova T, Soteres BJ, Stewart RR (1997) Neuronal progenitor cells derived from the anterior subventricular zone of the neonatal rat forebrain continue to proliferate in vitro and express a neuronal phenotype. Mol Cell Neurosci 8: 351–66
MacLusky NJ, Naftolin F (1981) Sexual differentiation of the central nervous system. Science 211: 1294–302
Maher P, Davis JB (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16: 6394–6401
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004–7
Mandelkow E (1999) Alzheimer’s disease — The tangled tale of tau. Nature 402: 588–589
Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E (1996) Structure, microtubule interactions, and phosphorylation of tau protein. Ann NY Acad Sci 777: 588–589
Manegold JC, Falkenstein E, Wehling M, Christ M (1999) Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol 45: 805–13
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon Pet al (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835–9
Mann JJ (1999) Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21 [2 Suppl]: 99S–105S
Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115–37
Manthey D, Heck S, Behl C (2000) The female sex hormone estrogen induces and increased release of soluble non-amyloidogeic b-amyloid precursor protein (sAPP) via the activation of mitogen-activated-protein-kinase (MAPkinase) and phosphokinase C (PKC). Neurobiol Aging S1–S114
Marcus R, Korenman SG (1976) Estrogen and the human male. In: Creger WP, Coggins CH, Hancock EW (eds) Annu Rev Med: Selected Topics in the Clinical Sciences, pp 357–370
Marder K, Sano M (2000) Estrogen to treat Alzheimer’s disease: Too little, too late? So what’s a woman to do? Neurology 54: 2035–2037
Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R (1998) Postmenopausal estrogen use and parkinsons disease with and without dementia. Neurology 50: 1141–1143
Maren S, De Oca B, Fanselow MS (1994) Sex differences in hippocampal long-term potentiation (LTP) and Pavlovian fear conditioning in rats: positive correlation between LTP and contextual learning. Brain Res 661: 25–34
Markesbery WR (1999) The role of oxidative stress in Alzheimer disease. Arch Neurol 56: 1449–1452
Marmont AM (2000) New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Annu Rev Med 51: 115–34
Marsden J (2000) Hormone replacement therapy and breast cancer. Maturitas 34 [Suppl 2]: S11—S24
Marsh L, Casper R (1998) Gender differences in brain morphology and in psychiatric disorders. In: Casper RC (ed) Women’s health: hormones, emotions and behavior. Psychiatry & Medicine, Cambridge University Press
Marte BM, Downward J (1997) PKB/AKT — Connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22: 355–358
Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA (1998) Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 57: 1041–52
Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer’s disease. J Neurosci 16: 5795–811
Masters CL, Beyreuther K (1998) Alzheimer’s disease. BMJ 316: 446–8
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249
Mattson MP (1998) Free radicals, calcium, and the synaptic plasticity-cell death continuum: emerging roles of the transcription factor NF-kappa B. Int Rev Neurobiol 42: 103–68
Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10: 243–254
Mattson MP, Guo Q, Furukawa K, Pedersen WA (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer’s disease. J Neurochem 70: 1–14
Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD (2000) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23: 222–229
Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B, Hauser A (1995) The frequency of idiopathic parkinsons disease by age, ethnic group, and sex in northern manhattan, 1988–1993. Am J Epidemiol 142: 1988–1993
McDonnell DP (1999) The molecular pharmacology of SERMs. Trends Endocrin Met 10: 301–311
McDonnell DP (2000) Selective estrogen receptor modulators (SERMs) A first step in the development of perfect hormone replacement therapy regimen. J Soc Gynecol Invest 7 [1 Suppl]: S10–5
McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW (1995) Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9: 659–69
McEwen BS (1980) The brain as a target organ of endocrine hormones. In: Kreiger DT, Hughes JS (eds) Neuroendocrinology. Sinaeur Associates, Sunderland, MA, pp 33–42
McEwen BS (2000) Protective and damaging effects of stress mediators: central role of the brain. Prog Brain Res 122: 25–34
McEwen BS, Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev 20: 279–307
McEwen BS, Alves SE, Bulloch K, Weiland NG (1997) Ovarian steroids and the brain: implications for cognition and aging. Neurology 48 [5 Suppl 7]: S8–15
McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 34: 251–9
McEwen BS, Gould E, Orchinik M, Weiland NG, Woolley CS (1995) Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes. In: Ciba Foundation Symposium 191, pp 52–73
McEwen BS, Jones KJ, Pfaff DW (1987) Hormonal control of sexual behavior in the female rat: molecular, cellular and neurochemical studies. Biol Reprod 36: 37–45
McGeer EG, McGeer PL (1999) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharmac Design 5: 821–836
McGeer PL, McGeer EG, Yasojima K (2000) Alzheimer disease and neuroinflammation. J Neural Transm [Suppl] 59: 53–57
McGuire WL (1978) Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428–33
McKay R (1997) Stem cells in the central nervous system. Science 276: 66–71
McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O’Malley BW (1999) Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem 69: 3–12
Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, Lithgow GJ (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289: 1567–1569
Mendelsohn ME, Karas RH (1994) Estrogen and the blood vessel wall. Curr Opin Cardiol 9: 619–26
Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801–11
Mendis T, Suchowersky O, Lang A, Gauthier S (1999) Management of Parkinson’s disease — A review of current and new therapies. Can J Neurol Sci 26: 89–103
Menini A (1999) Calcium signalling and regulation in olfactory neurons. Curr Opin Neurobiol 9: 419–426
Menon KM, Gunaga KP (1974) Role of cyclic AMP in reproductive processes. Fertil Steril 25: 732–50
Merchenthaler I, Shugrue PJ (1999) Estrogen receptor-beta: a novel mediator of estrogen action in brain and reproductive tissues. Morphological considerations. J Endocrinol Invest 22 [10 Suppl]: 10–2
Mermelstein PG, Becker JB, Surmeier DJ (1996) Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 16: 595–604
Merry DE, Korsmeyer SJ (1997) BCL-2 gene family in the nervous system. Annu Rev Neurosci 20: 245–267
Meyer M, Schreck R, Baeuerle PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005–2015
Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA (1999) Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis-and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. J Med Chem 42: 2456–68
Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F (1996) Tyrosine kinase/p2lras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292–300
Milgrom E, Atger M, Baulieu EE (1973) Studies on estrogen entry into uterine cells and on estradiol-receptor complex attachment to the nucleus — is the entry of estrogen into uterine cells a protein-mediated process? Biochim Biophys Act 320: 267–83
Miller DB, Ali SF, O’Callaghan JP, Laws SC (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 844: 153–65
Miller DK (1997) The role of the Caspase family of cysteine proteases in apoptosis. Semin Immunol 9: 35–49
Miller MM, Bennett HP, Billiar RB, Franklin KB, Joshi D (1998) Estrogen, the ovary, and neurotransmitters: factors associated with aging. Exp Gerontol 33: 729–57
Miller S, Mayford M (1999) Cellular and molecular mechanisms of memory: the LTP connection. Curr Opin Genet Develop 9: 333–7
Mills J, Laurent Charest D, Lam F, Beyreuther K, Ida N, Pelech SL, Reiner PB (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J Neurosci 17: 9415–22
Mogil JS (1999) The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 96: 7744–51
Mooradian AD (1993) Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45: 509–11 Moosmann B, Behl C (2000) Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. Eur J Biochem 267: 509–11
Moosmann B, Behl C (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96: 8867–8872
Moosmann B, Behl C (2000) Dietary phenols: Antioxidants for the brain? Nutr Neurosci 3: 1–10
Moosmann B, Uhr M, Behl C (1997) Neuroprotective potential of aromatic alcohols against oxidative cell death. FEBS Lett 413: 467–472
Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM, Naftolin F (1999) Estrogen and microglia: A regulatory system that affects the brain. J Neurobiol 40: 484–96
Morey AK, Pedram A, Razandi M, Prins BA, Hu RM, Biesiada E, Levin ER (1997) Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138: 3330–9
Moss RL, Gu Q, Wong M (1997) Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res 52: 33–69
Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR (1994) Synaptotropic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res 666: 151–167
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer’s Disease Cooperative Study. JAMA 283: 1007–15
Munaro NI (1978) The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology 26: 270–6
Murphy DD, Segal M (1997) Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc Natl Acad Sci USA 94: 1482–7
Naftolin F, Ryan KJ (1975) The metabolism of androgens in central neuroendocrine tissues. J Steroid Biochem 6: 993–7
Nakai M, Qin ZH, Chen JF, Wang Y, Chase TN (2000) Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem 74: 647–58
Nakano M, Sugioka K, Naito I, Takekoshi S, Niki E (1987) Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxyestrone and 2-hydroxy estradiol. Biochem Biophys Res Commun 142: 919–24
Namba H, Sokoloff L (1984) Acute administration of high doses of estrogen increases glucose utilization throughout brain. Brain Res 291: 391–4
Nardulli AM, Greene GL, Shapiro DJ (1993) Human estrogen receptor bound to an estrogen response element bends DNA. Mol Endocrinol 7: 331–40
Nass SJ, Davidson NE (1999) The biology of breast cancer. Hematol Oncol Clin N 13: 311
Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrin Rev 19: 647–72
Nicholson RI, Gee JMW (2000) Oestrogen and growth factor cross-talk and endocrine insen-sitivity and acquired resistance in breast cancer. Br J Cancer 82: 501–513
Noble BS, Reeve J (2000) Osteocyte function, osteocyte death and bone fracture resistance. Mol Cell Endocrinol 159: 7–13
Noble BS, Stevens H, Loveridge N, Reeve J (1997) Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20: 273–82
Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439–444 Oldendorf WH (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221: 439–444
Orwoll ES, Klein RF (1995) Osteoporosis in men. Endocr Rev 16: 87–116
Osborne CK, Fuqua SAW (2000) Selective estrogen receptor modulators: Structure, function, and clinical use. J Clin Oncol 18: 3172–3186
Osterlund M, Kuiper GG, Gustafsson JA, Hurd YL (1998) Differential distribution and regu-lation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res 54: 175–80
Oyama Y, Fuchs PA, Katayama N, Noda K (1994) Myricetin and quercetin, the flavonoid constituents of Gingko biloba extract, greatly reduce oxidative metabolism in both resting and Ca2t-loaded brain neurons. Brain Res 635: 125–129
Packard MG, Teather LA (1997) Intra-hippocampal estradiol infusion enhances memory in ovariectomized rats. Neuroreport 8: 3009–13
Packard MG, Teather LA (1997) Posttraining estradiol injections enhance memory in ovariec-tomized rats: cholinergie blockade and synergism. Neurobiol Learn Mem 68: 172–88
Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites. Science 277: 1508–10
Paganini-Hill A (1995) Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 38: 223–42
Pahl HL, Baeuerle PA (1994) Oxygen and the control of gene expression. Bioessays 16: 497–502
Palumbo A, Yeh J (1995) Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression. J Soc Gynecol Invest 2: 565–73
Pappas TC, Gametchu B, Watson CS (1995) Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9: 404–10
Pardridge WM, Moeller TL, Mietus LJ, Oldendorf WH (1980) Blood-brain barrier transport and brain sequestration of steroid hormones. Am J Physiol 239: E96–E102
Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 328: 176–83
Parnham M, Sies H, Ebselen (2000) Prospective therapy for cerebral ischaemia. Expert Opin Invest Drugs 9: 607–619
Parrizas M, Saltiel AR, Leroith D (1997) Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3’-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272: 154–161
Parthasarathy S, Santanam N, Ramachandran S, Meilhac O (1999) Oxidants and antioxidants in atherogenesis: an appraisal. J Lipid Res 40: 2143–2157
Parthasarathy S, Steinberg D, Witztum JL (1992) The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 43: 219–225
Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6: 2311–22
Pearlstein T, Rosen K, Stone AB (1997) Mood disorders and menopause. Endocrin Metab Clin 26: 279–94
Pecins-Thompson M, Brown NA, Bethea CL (1998) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 53: 120–9
Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL (1996) Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 16: 7021–9
Peschanski M, Defer G, N’Guyen JP, Ricolfi F, Monfort JC, Remy P, Geny C, Samson Y, Hantraye P, Jeny R et al (1994) Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson’s disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117: 487–99
Petanceska SS, Nagy V, Frail D, Gandy S (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer’s amyloid beta peptides in brain. Neurology 54: 2212–2217
Pettersson K, Grandien K, Kuiper GG, Gustafsson JA (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 11: 1486–96
Pfaff DW (1997) Hormones, genes, and behavior. Proc Natl Acad Sci USA 94: 142–136
Phillips SM, Sherwin BB (1992) Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17: 497–506
Pietras RJ, Szego CM (1975) Endometrial cell calcium and oestrogen action. Nature 253: 357–9
Pietras RJ, Szego CM (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265: 69–72
Pietras RJ, Szego CM (1980) Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 191: 743–60
Pike AC, Brzozowski AM, Roberts SM, Olsen OH, Persson E (1999) Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci USA 9: 8925–30
Pike CJ (1999) Estrogen modulates neuronal Bc1-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease. J Neurochem 72: 1552–63
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ’Hormonal’ risk factors, ’breast tissue age’ and the age-incidence of breast cancer. Nature 303: 767–70
Platet N, Cunat S, Chalbos D, Rochefort H, Garcia M (2000) Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol 14: 999-1009
Plouffe L (2000) Selective estrogen receptor modulators (SERMs) in clinical practice. J Soc Gynecol Invest 7: S38–S46
Poewe WH, Wenning GK (1998) The natural history of parkinsons-disease. Ann Neurol 44: S1–S9
Polkowski K, Mazurek AP (2000) Biological properties of genistein. A review of in vitro and in vivo data. Act Pol Pharm 57: 135–55
Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R (1998) The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 91: 459–66
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Diiorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinsons disease. Science 276: 2045–2047
Popovici RM, Kao LC, Giudice LC (2000) Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinol 141: 3510–3
Porter M, Penney GC, Russell D, Russell E, Templeton A (1996) A population based survey of women’s experience of the menopause. Br J Obstet Gynaecol 103: 1025–8
Post A, Holsboer F, Behl C (1998) Induction of nf-kappa-b activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells — suppression of nf-kappa-b and neuroprotection by antioxidants. J Neurosci 18: 8236–8246
Prasad KN, Clarkson ED, Larosa FG, Edwardsprasad J, Freed CR (1998) Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism — a review. Mol Genet Met 65: 1–9
Prasad KN, Cole WC, Kumar B (1999) Multiple antioxidants in the prevention and treatment of Parkinson’s disease. J Am Coll Nutr 18: 413–423
Prasad KN, Hovland AR, Cole WC, Prasad KC, Nahreini P, Edwards-Prasad J, Andreatta CP (2000) Multiple antioxidants in the prevention and treatment of Alzheimer disease: Analysis of biologic rationale. Clin Neuropharmacol 23: 2–13
Priest CA, Pfaff DW (1995) Actions of sex steroids on behaviours beyond reproductive reflexes. Ciba Foundation Symposium 191: 74–89
Rachez C, Freedman LP (2000) Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246: 9–21
Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695–700
Ramirez VD, Zheng J (1996) Membrane sex-steroid receptors in the brain. Front Neuroendocrin 17: 402–39
Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 13: 307–19
Redmond GP (1999) Hormones and sexual function. Intern J Fertil Wom Med 44: 193–7
Regier DA, Hirschfeld RM, Goodwin FK, Burke JD Jr, Lazar JB, Judd LL (1988) The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scien-tific basis. Am J Psychiatry 145: 1351–7
Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol 56: 359–384
Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB (1998) Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Hormon Behav 34: 171–82
Revelli A, Massobrio M, Tesarik J (1998) Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 19: 3–17
Ribeiro RCJ, Kushner PJ, Baxter JD (1995) The nuclear hormone receptor gene superfamily. Annu Rev Med 46: 443–453
Riddoch D, Jefferson M, Bickerstaff ER (1971) Chorea and the oral contraceptives. Brit Med J 4: 217–8
Rifici VA, Khachadurian AK (1992) The inhibition of low-density lipoprotein oxidation by 1743 estradiol. Metabolism 41: 1110–1114
Riggs BL, Melton LJ 3rd (1986) Involutional osteoporosis. N Engl J Med 314: 1676–86
Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J (1994) Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 42: 919–22
Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S, Garcia M (1998) Estrogen receptor mediated inhibition of cancer cell invasion and motility - an overview. J Steroid Biochem Mol Biol 65: 163–168
Rodriguez J, Garcia de Boto MJ, Hidalgo A (1996) Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci 5: 607–15
Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, et al (1992) Complement activation by b-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89, 10016–10020
Roof RL, Hall ED (2000) Title Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone. J Neurotraum 17: 367–388
Roof RL, Havens MD (1992) Testosterone improves maze performance and induces development of a male hippocampus in females. Brain Res 572: 310–3
Roof RL, Zhang Q, Glasier MM, Stein DG (1993) Gender-specific impairment on Morris water maze task after entorhinal cortex lesion. Behav Brain Res 57: 47–51
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng H-X, Rhamani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Vanden-Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993) Mutations in the Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59–62
Rosenzweig MR, Leiman AL, Breedlove SM (1999) Biological Psychology, 2nd edn. Sinauer Associates Inc, Sunderland Publishers
Roses AD (1997) Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 4: 170–185
Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114: 919–23
Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44: 839–50
Rupprecht R (1997) The neuropsychopharmacological potential of neuroactive steroids. J Psychiatry Res 31: 297–314
Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410–6
Rupprecht R, Reul JM, Trapp T, van Steensel B, Wetzel C, Damm K, Zieglgansberger W, Holshoer F (1993) Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11: 523–30
Rydel RE, Greene LA (1988) cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA 85: 1257–61
Sack MN, Rader DJ, Cannon RO 3rd (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343: 269–70
Sagara Y (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71: 1002–12
Saibil H (2000) Molecular chaperones: containers and surfaces for folding, stabilising or unfolding proteins. Curr Opin Struc Biol 10: 251–8
Salas E, Lopez MG, Villarroya M, Sanchez-Garcia P, De Pascual R, Dixon WR, Garcia AG (1994) Endothelium-independent relaxation by 17-alpha-estradiol of pig coronary arteries. Eur J Pharmacol 258: 47–55
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grandma M, Woodbury P, Growdon Cotman CW, Pfeiffer E et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 336: 1216–1222
Santagati S, Melcangi RC, Celotti F, Martini L, Maggi A (1994) Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem 63: 2058–64
Santanam N, Shem-Brewer R, McClatchey R, Castellano PZ, Murphy AA, Voelkel S, Parthasarathy S (1998) Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res 39: 2111–8
Sapolsky RM (1992) Stress, the aging brain, and the mechanisms of neuron death. MIT Press, Cambridge Massachusetts, London England
Sapolsky RM (1996) Why stress is bad for your brain. Science 273: 749–50
Sapolsky RM (1999) Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol 34: 721–32
Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S (1999) The effect of estrogen replacement on early Parkinson’s disease. Neurology 52: 1417–1421
Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S (1998) Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 54: 707–719
Sawada H, Ibi M, Kihara T, Urushitani M, Honda K, Nakanishi M, Akaike A, Shimohama S (2000) Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J 14: 1202–1214
Sawada H, Shimohama S (2000) Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 24: 143–147
Scallet AC (1999) Estrogens: neuroprotective or neurotoxic? Ann NY Acad Sci 890: 121–32
Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW (1996) Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93: 10614–9
Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang JP, Johnson-Wood Khan K, Kholodenko D, Lee M, Liao ZM, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature 400: 173–177
Schenk DB, Seubert P, Lieberburg I, Wallace J (2000) Beta-peptide immunization — A possible new treatment for Alzheimer disease. Arch Neurol 57: 934–936
Schmidt BMW, Gerdes D, Feuring M, Falkenstein E, Christ M, Wehling M (2000) Rapid, nongenomic steroid actions: A new age? Front Neuroendocrin 21: 57–94
Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-KB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5 554–559
Schneider LS (1998) Cholinergic deficiency in Alzheimer’s disease. Pathogenic model. Am J Geriatr Psych 6 [2 Suppl 11: S49–55
Schneider LS, Farlow M (1997) Combined tacrine and estrogen replacement therapy in patients with Alzheimer’s disease. Ann NY Acad Sci 826: 317–22
Schneider LS, Farlow MR, Pogoda JM (1997) Potential role for estrogen replacement in the treatment of Alzheimer’s dementia. Am J Med 103: 46S–50S
Schneider LS, Finch CE (1997) Can estrogens prevent neurodegeneration? Drug Aging 11: 87–95
Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxe-tine Collaborative Study Group. Am J Geriatr Psych 5: 97–106
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF—KB transcription factor and HIV-1. EMBO J 10: 2247–2258
Schubert D, Behl C (1993) The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 629: 275–282
Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904–4911
Seelig A, Gottschlich R, Devant RM (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci USA 91: 68–72
Seeman MV (1996) The role of estrogen in schizophrenia. J Psychiatry Neurosci 21: 123–127
Seeman MV (1997) Psychopathology in women and men — focus on female hormones. Am J Psychiatry 154: 1641–1647
Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature.399: A23–31
Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–716
Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G (1994) Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 10: 41–2
Shaul PW (1999) Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 64: 28–34
Sherwin BB (1988) Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13: 345–57
Sherwin BB (2000) Mild cognitive impairment: Potential pharmacological treatment options. J Am Geriat Soc 48: 431–441
Shi J, Simpkins JW (1997) 17beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol 272: E1016–22
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927–937
Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O’Malley BW (1997) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52: 141–65
Shoulson I (1998) Datatop — a decade of neuroprotective inquiry. Ann Neurol 44: S160–S166
Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Compar Neurol 388: 507–25
Shughrue PJ, Merchenthaler I (2000) Estrogen is more than just a “sex hormone”: novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuroendocrin 21: 95–101
Shughrue PJ, Scrimo PL Merchenthaler I (1998) Evidence for the colocalization of estrogen receptor-beta mRNA and estrogen receptor-alpha immunoreactivity in neurons of the rat forebrain. Endocrinology 139: 5267–70
Shughrue PJ, Scrimo PJ, Merchenthaler I (2000) Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain. Neuroscience 96: 41–9
Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN (1998) The Women’s Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 19: 604–21
Shwaery GT, Vita JA, Keaney JF Jr (1997) Antioxidant protection of LDL by physiological concentrations of 17beta-estradiol. Requirement for estradiol modification. Circulation 95: 1378–85
Shy H, Malaiyandi L, Timiras PS (2000) Protective action of 17beta-estradiol and tamoxifen on glutamate toxicity in glial cells. Int J Develop Neurosci 18: 289–97
Sies H (1993) Strategies of antioxidant defense. Eur J Biochem 215: 213–9
Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291–5
Sies H, Stahl W (1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62 [6 Suppl]: 1315S–1321S
Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538–41
Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC, Rajakumar G (1997) Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer’s disease. Am J Med 103: 19S–25S
Simpkins JW, Singh M, Bishop J (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and ncurodegeneration associated with Alzheimer’s disease. Neurobiol Aging 15 [Suppl 2]: S 195–7
Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19: 2455–2463
Singer CA, Rogers KL, Dorsa DM (1998) Modulation of Bel-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9: 2565–8
Singer TP, Ramsay, PR (1995) Monoamine oxidases: old friends hold many surprises. FASEB J 9: 605–610
Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136: 2320–4
Singh M, Setalo G Jr, Guan X, Frail DE, Toran-Allerand CD (2000) Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J Neurosci 20: 1694–1700
Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD (1999) Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19: 1179–88
Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56: 131–7
Skaper SD, Fabris M, Ferrari V, Dalle Carbonare M, Leon A (1997) Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radical Bio Med 22: 669–678
Skoog I (2000) Vascular aspects in Alzheimer’s disease. J Neural Transm [Suppl] (59): 37–43
Slemenda CW (1993) Risk factors for low bone mass: clinical implications. Ann Intern Med 118: 741–2
Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzhei-mer’s disease. Biochim Biophys Act - Molecular Basis of Disease 1502: 139–144
Soderling TR (2000) CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol 10: 375–380
Sohrabji F, Miranda RC, Toran-Allerand CD (1994) Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 14: 459–71
Sohrabji F, Miranda RC, Toran-Allerand CD (1995) Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92: 11110–4
Spillantini MG, Goedert M (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21: 428–433
Squire LR (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99: 195–231
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH (1991) Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med 325: 756–62
Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963–6
Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer’s disease. J Neurosci 18: 3180–5
Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE (1997) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143: 313–8
Strijks E, Kremer JA, Horstink MW (1999) Effects of female sex steroids on Parkinson’s disease in postmenopausal women. Clin Neuropharmacol 22: 93–7
Studd J (1997) Depression and the menopause. Oestrogens improve symptoms in some middle aged women. BMJ 314: 977–8
Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski (1993) Antioxidant potential of specific estrogens and lipid peroxidation. J Clin Endocrinol Metab 77: 1095–1097
Sugioka K, Shimosegawa Y, Nakano M (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210: 37–9
Tan SL, Wood M, Maher P (1998) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem 71: 95–105
Tanapat P, Hastings NB, Reeves AJ, Gould E (1999) Estrogen stimulates a transient increase in the number of new neurons in the dentate gyms of the adult female rat. J Neurosci 19: 5792–801
Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age of onset of Alzheimer’s disease. Lancet 348: 429–432
Tao Y, Black IB, DiCicco-Bloom E (1996) Neurogenesis in neonatal rat brain is regulated by peripheral injection of basic fibroblast growth factor (bFGF). J Compar Neurol 376: 653–63
Tenover JL (1999) Testosterone replacement therapy in older adult men. Int J Androl 22: 300–6
Terao J, Piskula M, Yao Q (1994) Protective effect of epicatechin, epicatechin gallate, and quer-cetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys 308: 278–284
Terry RD, Katzman R, Bick KL (1994) Alzheimer Disease. Raven Press, New York
Tesarik J, Mendoza C (1995) Nongenomic effects of 17beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 80: 1438–43
Teyler TJ, Vardaris RM, Lewis D, Rawitch AB (1980) Gonadal steroids: effects on excitability of hippocampal pyramidal cells. Science 209: 1017–8
Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270: 593–8
Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME et al (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534–44
Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE (1998) Population-based study of risk of breast cancer in carriers of brca2 mutation. Lancet 352:. 1337–1339
Thomberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312–6
Toft D, Gorski J (1966) A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci USA 55: 1574–81
Tohgi H, Utsugisawa K, Yamagata M, Yoshimura M (1995) Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res 700: 245–53
Tomkinson A, Reeve J, Shaw RW, Noble BS (1997) The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128–35
Toran-Allerand CD (1996) The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 18: 36–48
Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89: 4668–72
Toran-Allerand CD, Singh M, Setalo G Jr (1999) Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrin 20: 97–121
Toung TJ, Traystman RJ, Hum PD (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29: 1666–70
Traber MG, Sies H (1996) Vitamin E in humans: demand and delivery. Annu Rev Nutr 16: 321–47
Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V (1997) Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11: 353–65
Tremblay GB, Tremblay A, Labrie F, Giguere V (1999) Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19: 1919–1927
Trent JM, Bittner M, Zhang J, Wiltshire R, Ray M, Su Y, Gracia E, Meltzer P, De Risi J, Penland L, Brown P (1997) Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma. Clin Exp Immunol 107 [Suppl 1): 33–40
Tsujimoto Y, Shimizu S (2000) Bc1–2 family: Life-or-death switch. FEBS Letters 466: 1–2
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-x-induced apoptosis by NF-a. Science 274: 787–789
Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller L, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secre-tase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735–741
Veld BAI, Launer LJ, Hoes AW, Ott A, Hofman A, Breteler MMB, Stricker BHC, (1998) NSAIDs and incident Alzheimer’s disease. The Rotterdam study. Neurobiol Aging 19: 607–611
Venkov CD, Rankin AB, Vaughan DE (1996) Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94: 727–33
Verheul HAM, Coelingh-Bennink HJT, Kenemans P, Atsma WJ, Burger CW, Eden JA, Hammar M, Marsden J, Purdie DW (2000) Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies. Maturitas 36: 1–17
Verma IM, Stevenson JK, Schwarz EM, Vanantwerp D, Miyamoto S (1995) REL/NF-KAPPA-B/I-KAPPA-B family - intimate tales of association and dissociation. Gen Dev 9: 2723–2735
Voet D, Voet JG, Pratt CW (1999) Fundamentals of Biochemistry.Jon Wiley & Sons, Inc.
Wagner GC, Tekirian TL, Cheo CT (1993) Sexual differences in sensitivity to methamphet-amine toxicity. J Neural Transm 93: 67–70
Wagner JP, Black IB, DiCicco-Bloom E (1999) Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 19: 6006–16
Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M et al (1985) Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82: 7889–93
Walton M, Sirimanne E, Williams C, Gluckman P, Dragunow M (1996) The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res 43: 21–9
Walton MR, Dragunow M (2000) Is CREB a key to neuronal survival? Trends Neurosci 23: 48–53
Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-1(13. Science 274: 784–787
Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan20-one. J Clin Endocrinol Metab 81: 1076–82
Wang Q, Santizo R, Baughman VL, Pelligrino DA (1999) Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30: 630–636
Warmuth MA, Sutton LM, Winer EP (1997) A review of hereditary breast cancer - from screening to risk factor modification. Am J Med 102: 407–415
Warner M, Nilsson S, Gustafsson JA (1999) The estrogen receptor family. Curr Opin Obstet Gyn 11: 249–54
Watson SJ, Akil H (1999) Gene chips and arrays revealed: a primer on their power and their uses. Biol Psychiatry 45: 533–43
Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138: 4030–3
Watters JJ, Dorsa DM (1998) Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18: 6672–80
Weaver CE, Parkchung M, Gibbs TT, Farb, DH (1997) 17-beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761: 338–341
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91: 5212–6
Weinmaster G (1997) The ins and outs of notch signaling. Mol Cell Neurosci 9: 91–102
Wetzel CH, Hermann B, Behl C, Pestel E, Rammes G, Zieglgansberger W, Holsboer F, Rupp-recht R (1998) Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol 12: 1441–51
Weyler W, Hsu, YPP, Breakefield XO (1990) Biochemistry and genetics of monoaminooxidase. Pharmacol Ther 47: 391–417
White R, Lees JA, Needham M, Ham J, Parker M (1987) Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol 1: 735–44
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237–9
Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74: 589–607
Whooley MA, Grady D, Cauley JA (2000) Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Int Med 15: 535–541
Willingham MC (1999) Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 47: 1101–10
Wolf OT, Kudielka BM, Hellhammer DH, Torber S, McEwen BS, Kirschbaum C (1999) Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 24: 727–741
Wolozin B, Behl C (2000) Mechanisms of neurodegeneration disorders part 1: Protein aggregates. Arch Neurol 57: 793–796
Wolozin B, Behl C (2000) Mechanisms of neurodegenerative disorders part 2: Control of cell death. Arch Neurol 57: 801–804
Wolozin B, Iwasaki K, Vito P, Ganjei K, Lacana E, Sunderland T, Zhao B, Kusiak J, Wasco W, D’Adamio L (1996) Participation of presenilin-2 in apoptosis: Enhanced basal activity conferred by Alzheimer mutation. Science 274: 1710–3
Wong M, Moss RL (1992) Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CAI neurons. J Neurosci 12: 3217–25
Woolley CS (1998) Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav 34: 140–8
Woolley CS (1999) Electrophysiological and cellular effects of estrogen on neuronal function. Crit Rev Neurobiol 13: 1–20
Woolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12: 2549–54
Woolley CS, McEwen BS (1993) Roles of estradiol and progesterone in regulation of hippo-campal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336: 293–306
Wooten MW (1999) Function for NF-icB in neuronal survival: Regulation by atypical protein kinase C. J Neurosci Res 58: 607–611
Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251–306
Xiao L, Becker JB (1998) Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release. Synapse 29: 379–91
Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4: 447–451
Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279: 688–95
Yagi K (1997) Female hormones act as natural antioxidants - a survey of our research. Acta Biochim Pol 44: 701–709
Yang D, Kuan C, Whitmarsh A, Rincon M, Zheng T, Davis R, Rakic P, Flavell R (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 389: 368–72
Yang F, Sun X, Beech W, Teter B, Wu S, Sigel J, Vinters HV, Frautschy SA, Cole GM (1998) Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer’s disease. Am J Pathol 152: 379–89
Yang SH, Shi J, Day AL, Simpkins JW (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31: 745–749
Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimers disease. Neuron 16: 921–932
Young RA (2000) Biomedical discovery with DNA arrays. Cell 102: 9–15
Zhang Y, Dawson VL, Dawson TM (2000) Oxidative stress and genetics in the pathogenesis of Parkinson’s disease. Neurobiol Dis 7: 240–250
Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE (1993) BCL-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90: 4533–7
Zhou Y, Watters JJ, Dorsa DM (1996) Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137: 2163–6
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Wien
About this chapter
Cite this chapter
Behl, C. (2001). References. In: Estrogen — Mystery Drug for the Brain?. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6189-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6189-0_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7254-4
Online ISBN: 978-3-7091-6189-0
eBook Packages: Springer Book Archive